Since C3H/HeJ mice support small immune responses to LPS and no mitogenic responses to LPS, we refer to these mice as low LPS responders. In contrast, other similar strains of C3H mice we have tested are high LPS responders. Such high LPS responder C3H strains produce large immune responses to LPS over a wide dose range in vivo, and spleen cultures prepared from these high LPS responder mice all support mitogenic responses to LPS. LPS prepared from a variety of strains of Escherichia coli or Salmonella fail to elicit in vivo immune responses or in vitro mitogenic responses in C3H/HeJ mice but elicit both responses in high LPS responder C3H strains. The data from backcross experiments are presented which reveal that the failure of C3H/HeJ mice to support in vitro mitogenic responses and in vivo immune responses to LPS seems to be due to a single gene defect. This autosomal gene is not linked to the histocompatibility or to heavy-chain allotype loci. These findings imply that the immune response and mitogenic response induced by LPS share a common regulatory mechanism.
Materials and Methods
Mice. The following strains of mice were obtained from Jackson Laboratories, Bar Harbor, Maine: C3H/HeJ, C3HeB/FeJ, C3H/DiSn (all H-2~), DBA/2J (H-2n), and C3D2F1 (C3H/HeJ x DBA/2J). C3H/Str mice were obtained from Strong Laboratories, Del Mar, Calif. The breeding nuclei of C3H.SW (CSW) and C3H.SW-Ig-1 b (CWB/13) strains were obtained from Dr. Leonard Herzenberg, Stanford University, Stanford, Calif. C3H.SW (H-2 °) is congenic with C3H/DiSn; C3H.SW-Ig-1 b differs in IgG2a immunoglobulin allotype from the other C3H strains. (CWB x C3H/HeJ)F1 and (F1 × C3H/HeJ) backcross mice were bred at the Salk Institute, San Diego, Calif. The following strains were obtained from Dr. Donald Schreffier, University of Michigan, Ann Arbor, Mich., C3H/Sf, C3H.OL, C3H.OH, C3H.Q, and C3H.B10. Mice were between 6 and 12 wk of age at the beginning of immunization.
Lipopolysaccharides. The following bacterial lipopolysaccharides, prepared by the Westphal procedure, were obtained from Difco Laboratories, Detroit, Mich.: E. coil 0127:B8, E. coli 0111:B4, E. coli 0113, E. coli 026:B6, E. coli 0128:B12, and E. coli 055:B5; and Salmonella abortis equi, S. flexerni, S. marcescens, S. typhosa, S. typhimurium, and S. enteriditis. S. paratyphi C was a gift from Dr. S. Sarkar, Salk Institute. Each LPS preparation was resuspended in a phosphate-buffered saline (pH 7.2) at a concentration of 1 mg/ml and boiled for 60 min before use. Lipid A was prepared from E. coli 0127:B8 LPS as described elsewhere (8) .
Immune Responses to LPS. Mice were injected intraperitoneally with 0.1 ml of LPS solutions as described in the text. At day 7, animals were bled to provide serum samples for hemagglutination assays, or animals were sacrificed and their spleens removed to determine the number of LPS-specific antibody-forming cells. LPS-coated sheep erythrocytes (SRBC) were used as indicator cells for both hemagglutination and plaque assays. An aliquot containing 0.1 ml packed SRBC was incubated with 0.5 ml LPS (1 mg/ml) at 37°C for 60 min, and cells were then washed five times with a balanced salt solution (11) . The LPS-coated erythrocytes were resuspended at a dilution of 1:15 for the hemolytic plaque assay or 1:100 for the hemagglutination assay. The number of antibody-forming cells was determined using a microscope slide modification of the Jerne plaque assay (12) . Each spleen cell preparation was assayed on SRBC and LPS-coated SRBC, the difference being the LPS-specific plaque-forming cells (PFC). The hemagglutination assay used is described elsewhere2 The hemagglutination data is presented as a reciprocal of the end point dilution at which hemagglutination was observed, the initial serum dilution was always 1:10.
Mitogenic Responses to LPS. Spleen cultures were prepared in RPMI-1640 medium (Microbiological Associates, Inc., Bethesda, Md.) supplemented with 5% fetal bovine serum (lot no. 728E309, International Scientific Industries, Cary, Ill.) as detailed elsewhere (8) . Each culture contained 1 ml 3Riblet, R., and M. Weigert. 1974. Manuscript in preparation. medium, 5 × 10 e spleen cells, and the amount of LPS described in the text. Cultures were rocked at 5-7 cycles/min (12) at 37°C for 66 h and then incubated for 6 h with 0.5 #Ci [SH]thymidine (52 Ci/mmol, New England Nuclear, Boston, Mass.), 10-b M thymidine, and 10-7 M fluorodeoxyuridine. The cells from each culture were then collected by filtration through glass fiber membranes (Whatman GF/C). The filters were then washed successively with 5% TCA and 95% ethanol, dried, and radioactive measurements made using a terphenyl-toluene scintillation fluid (8) .
Allotype Determination. The backcross mice were tested for the presence of the Ig-1 b allotype of the CWB grandparent by using Ouchterlony double-diffusion testing with a BALB/c anti-BAB/14 (Ig-l" anti-Ig-P) antiallotype serum (13) .
H-2 Typing. The backcross mice. were tested for the presence of the H-2 b allele from the CWB grandparent by a modification of the polyvinylpyrrolidone technique of Rubinstein and Kaliss (14) . The agglutination reactions were performed in 10 × 75-mm glass tubes. Rather than reading the reactions microscopically (14) the tubes were simply inverted, drained, and leaned against a nearly vertical light box. The cells were observed as they drained slowly down the tube. Positive agglutination was easily seen as the cells drained as large islands with a rather oily appearance as compared to the finely granular aspect of the nonagglutinated cells. The testing was done with a single dilution, 1:500, of the anti-H-2 serum and compared with a parallel reaction with a normal serum at 1:500. The typing serum was a pool of hyperimmune sera taken after eight weekly intraperitoneal injections of C3H/HeJ mice with spleen, thymus, and mesenteric lymph node cells from CSW mice, the cells from 1 donor were divided among 10 recipients each week. This yielded a strong congenic H-2 ~ anti-H-2 ~ typing serum. Fig. 1 Fig. 2 compare the mitogenic responses to LPS in spleen cultures prepared from F~ hybrid mice to those prepared from the parental strains. C3H/HeJ × DBA/2J (C3D2F1) and (C3H/HeJ × CWB)F1 hybrid mice both support mitogenic responses to LPS that are similar to those observed in cultures from parental CWB or DBA/2J mice. Therefore, mitogenic responsiveness to LPS is a dominant trait (Fig. 2) . The mitogenic response of C3H/HeJ and C3HeB/FeJ spleen cells to a variety of different types of LPS was analyzed. Six types of E. coli LPS and seven types of Salmonella LPS were compared (Table I ). All LPS preparations stimulated mitogenic responses in C3HeB/FeJ spleen cultures. In comparison, all LPS preparations were only weakly or nonmitogenic in spleen cultures prepared from C3H/HeJ mice (Table I) . Weak mitogenic responses observed in C3H/HeJ spleen cultures were always less than fourfold above background. Similar concentrations of LPS in C3HeB/FeJ spleen cultures resulted in stimulations generally greater than 10-fold (Table I) .
Results

Mitogenic Responses to LPS. The data presented in
The data presented in Fig. 3 compare mitogenic responses to lipid A prepared from E. coli 0127:B8 LPS. Lipid A is nonmitogenic in C3H/HeJ spleen cultures but is mitogenic in C3HeB/FeJ spleen cultures.
Immune responses to LPS. The data presented in Fig. 4 compare the in vivo LPS tested, the immune response as determined by antibody-forming cells in the spleen, was greater in C3HeB/FeJ than C3HfdeJ mice. Only in the range of 1-10 ~g LPS were immune responses to LPS observed in C3H/HeJ mice. Only IgM responses to LPS were observed (data not shown) consistent with reports of others (11). In Fig. 5 the serum titers to E. coil 0127:B8 LPS in C3H/HeJ and C3HeB/FeJ mice on day 7 are described. As observed for the spleen antibodyforming cells, the serum titers in C3H/HeJ mice in the range of 1.0-10 ug consistently show significant increases above the background titers. However, serum titers to LPS in C3HeB/FeJ mice show two very consistent differences. In the range of 1.0-10 ug LPS titers are generally fourfold higher than observed in C3H/HeJ mice. Also, lower (0.1 ~g) and higher (10-200 ~g) concentrations of LPS elicit significant antibody responses, where as small or no immune responses are seen in C3H/HeJ mice (Fig. 5) .
The categorization of C3H strains as either high or low LPS responders is most easily accomplished when LPS is administered at low ( < 1 ~g) and high ( > 10 ~g) doses. In all subsequent experiments reported here we have administered 100 ~g LPS intraperitoneally to C3H mice to reveal the maximum immune response differences between the low and high LPS responder strains as determined by serum hemagglutination titers and spleen PFC numbers.
The data presented in Fig. 6 show immune responses to 100 ~g E. coli 0127:B8 LPS in C3H/HeJ, CWB, (C3H/HeJ × CWB)FI, C3H/Str, and C3H/DiSn mice. No immune response to LPS was seen in C3H/HeJ mice, while responses were elicited in all other strains. Repeated injections of 100 #g LPS to these mice show no significant increase in serum titers (data not presented). As in the mitogenic response, F, hybrid mice of a high and low responder strain are also high LPS responders (Fig. 6) .
The response of C3H strains to different types of E. coli and Salmonella LPS preparations is similar to that described for E. coli 0127:B8 LPS. When C3H/HeJ and C3HeB/FeJ mice were immunized with 100 tLg E. coli 0111:B4, E. coli 0127:B8, E. coli 0113, S. paratyphi C, and S. marcescens LPS, immune responses to these LPS preparations were always higher in C3HeB/FeJ mice than C3H/HeJ mice (Fig. 7) . Backcross Linkage Analysis. The backcross mice from (C3H/HeJ × CWB)FI × C3H/HeJ mice were examined for the ability to elicit in vivo immune responses and in vitro mitogenic responses to E. coli 0127:B8 LPS. Each mouse was prebled to determine the background serum titer to LPS, and then immunized with 100 pg LPS. After 7 days the immune sera were analyzed for an increase in titer to LPS. Each backcross animal was also typed for the Ig-1 b
tl. Q. In vivo immune responses to various E. coli and Salmonella LPS in C3H/HeJ and C3HeB/FeJ mice. Groups of three mice were injected with 100 tLg of the LPS preparation described and after 7 days LPS-specific PFC in the spleens determined. There was no significant difference in the cell numbers from C3H/HeJ and C3HeB/FeJ spleens. The mean PFF/spleen from each group is presented. The background response (unimmunized) of both mouse strains to these LPS preparations is in the range of 500 PFC/spleen.
allotype and H-2 b characteristic of CWB mice. A total of 44 backcross mice have been individually assayed in this manner and the data obtained from each mouse is presented in Table II . In control C3H/HeJ mice which were not immunized with LPS, no immune or mitogenic responses to LPS were observed. However in immunized C3H/HeJ mice slight increases in serum titers to LPS and in the mitogenic response occur (Table II) . Of the 44 backcross mice tested, 24 mice were categorized as high LPS responders on the basis that immunization with LPS resulted in significant increases in serum titers to LPS, and ~n subsequent spleen assays, mitogenic responses to LPS were always elicited (Table II) . The remaining 20 mice were all classed as low LPS responders. While none of these low LPS responders showed significant in vivo immune responses to LPS,-spleen cultures prepared from four of these animals (A1, El, F1, and F7; Table II) supported small mitogenic responses to LPS. Similar increases in mitogenic responsiveness are sometimes seen in C3H/HeJ mice which have been preimmunized with LPS (Table II) . Since such mitogenic responses generally never exceed a fourfold stimulation, and are much smaller than observed in high LPS responder mice, the responses have been designated as low. These backcross data clearly show that the ability to support immune and mitogenic responses to LPS segregate together, and since there are similar numbers of high and low LPS responder mice the defect in C3H/HeJ mice may be due to a single gene.
There is no correlation in backcross mice between H-2, allotype, and LPS responsiveness. The loci governing the expression of each of these traits segregate independently. Therefore the classification of C3H mice as high and low LPS responders is not a distinction that is linked to the expression of H-2 or heavy-chain allotype loci, and is not sex-linked (Table III) .
Discussion
The experiments reported in this paper demonstrate that strains of C3H mice can be classified as high or low responders to bacterial LPS. Responsiveness is defined in two ways: the ability to elicit in vivo immune responses to LPS and the ability to support in vitro mitogenic responses to LPS. When compared in these two LPS response systems, C3H/HeJ mice are low LPS responders whereas C3HeB/FeJ, C3H/Str, C3H/DiSn, C3H/Sf, C3H.SW (CSW), and C3H.SW-Ig-1 b (CWB) are high LPS responders. In the mitogenic assay, C3H/HeJ spleen cells generally support no response to LPS (Fig. 1) . However, the in vivo immune response difference to LPS between C3H/HeJ mice and other C3H strains is a quantitative difference (Figs. 4 and 5) . Doses of 1.0-10 #g LPS elicit small IgM responses in C3H/HeJ mice. Lower or higher doses of LPS fail to elicit significant immune responses. In contrast, other C3H strains elicit a much greater immune response to LPS over a much wider dose range (0.1-200 tLg) (Fig. 5) . We have used an immunizing dose of 100 ug LPS to obtain the maximum immune response difference between C3H/HeJ and other C3H strains. The ability to respond well to LPS in C3H mice is dominant, as shown by the response of the F~ hybrid of a high responder (CWB) and a low responder (C3H/HeJ) strain (Fig. 2) .
Responsiveness to LPS has several interesting characteristics. Spleen cultures from C3H/HeJ mice do not support mitogenic responses to a variety of noncross-reacting LPS preparations from E. coli or Salmonella (Table I) . However, the active region for the mitogenic activity of LPS is lipid A which has a common structure (15) . In vivo, C3H/HeJ mice also fail to support an immune response to high doses of these LPS preparations (Fig. 7) . The antigenic determinants are found mainly in the polysaccharide moiety of LPS and are very different in E. coli and Salmonella preparations. Mitogenic responses elicited by LPS require the interaction of lipid A with the surface of most B lymphocytes (7, 8, 15) . In contrast, the induction of immune responses to LPS results from the interaction of antigenic determinants in the polysaccharide region with immunoglobulin receptors on B lymphocytes (1, 2, 16 ). Whereas most B lymphocytes ap- pear to respond mitogenically to LPS (7), very few respond by synthesizing specific antibody to LPS. The analysis of backcross mice revealed that immune and mitogenic responsiveness segregated together and that the defect in C3H/HeJ mice that limits mitogenic and immune responses to LPS appears to be due to a single locus (Table II) . The H-2 and allotype characteristics of the high and low LPS responder backcross mice were also analyzed (Tables II and III) . These data show that the defective locus in C3H/HeJ mice is not associated with the major histocompatibility complex (H-2) or to the heavy-chain allotype region. This is consistent with the fact that we have seen no response difference with any of the H-2 or allotype congenic strains.
There have been a number of reports concerning the response of C3H/HeJ mice to LPS or lipid A. When immunized with high concentrations of lipid A, C3H/HeJ mice unlike other strains, fail to show an increase in PFC directed against normal SRBC (17) . C3H/HeJ are resistant to the lethal toxic effects of LPS and increase their mononuclear cells in the peritoneal cavity after LPS stimulation (3, 18) . The toxic and mononuclear cell response in C3H/HeJ mice appears to be under polygenic control (18) unlike control of immune and mitogenic responses to LPS described here. There are several genetic analyses of immune responses to LPS in other strains of mice. Di Pauli (19) has shown differences in the response of mice to Salmonella LPS. BALB/c and DBA/2An differ in the antibody specificity produced against the same LPS. This strain difference residues in the process that recognizes the antigen and is not due to a lack of antibody-producing precursor cells in BALB/c and DBA/2An mice (19) . Backcross analyses show that this immune response difference to LPS may be controlled by a single gene (20) .
A number of loci have been identified in mice that influence immune responses to different antigens: one maps within the H-2-gene complex (21) (22) (23) , another group is linked to heavy-chain allotype loci (24) (25) (26) (27) (28) , and a third is sex-linked (29, 30) . It is unlikely that the defect in C3H/HeJ mice that limits LPS responsiveness is associated with any of these loci. The immune responsiveness to LPS is not sex-linked (Tables II and III) . Therefore the defect in C3H/HeJ mice is unrelated to the defect in CBA/HN mice which limits their immune responses to a variety of antigens (29, 30) . CBA/HN mice lack an X-linked gene that governs the level of the IgM response.
The defect in C3H/HeJ mice which limits the level of the IgM response to bacterial LPS appears different from other immune response defects detected in mice. In view of the finding that C3H/HeJ mice are low responders to a variety of unrelated LPS, and do not respond mitogenically to either LPS or lipid A, it is puzzling that the backcross animals revealed that both LPS responses are governed by a single locus. LPS has a variety of physiological effects on mice. It has immunogenic, mitogenic, pyrogenic, and toxic properties and affects the distribution of neutrophils and monocytes (references 3, 10, 17, and 18, and footnote 2). Since C3H/HeJ mice have been reported to show defects in many such LPS-induced responses (3, 9, 17, 18) , it is necessary to analyze the linkage of immune and mitogenic responses in backcross animals to other LPS-induced responses to determine if other responses are also regulated by the locus we have The defect in C3H/HeJ mice that limits mitogenic and immune responsiveness to be due to a single autosomal gene which is not linked to the H-2 histocompatibility or heavy-chain allotype loci.
